In this context, a patient who had food poisoning months earlier may already be at increased risk for microbial overgrowth, and additional slowing of gut motility (such as that associated with GLP-1 therapy) could further compound that risk
We previously reported that antibodies against phosphoenolpyruvate carb kinase and proprotein convertase subtilisin/kexin type 9 are increased in patients with diabetes and associated with poor prognoses 2,3
Significance of monitoring the levels of thyroid hormone antibodies and glucose and lipid metabolism antibodies in patients suffer from type 2 diabetes
Myokine-adipokine cross-talk: potential mechanisms for the association between plasma irisin and adipokines and cardiometabolic risk factors in Mexican children with obesity and the metabolic syndrome
Several GLP-1RAs trials have demonstrated that these agonists reduce cardiovascular risk factors, including glycated hemoglobin (HbAc1) values, systolic blood pressure, and body weight (Shapiro, 1998), the dynamic balance of MMPs/TIMPs maintains the stabilization of the ECM
